BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2849028)

  • 1. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp.
    Johnson WM; Lior H
    Microb Pathog; 1988 Feb; 4(2):115-26. PubMed ID: 2849028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material.
    Johnson WM; Lior H
    Microb Pathog; 1988 Feb; 4(2):103-13. PubMed ID: 2849027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of cytolethal distending toxin (CLDT) by Campylobacter fetus subsp. fetus isolated from calves.
    Ohya T; Tominaga K; Nakazawa M
    J Vet Med Sci; 1993 Jun; 55(3):507-9. PubMed ID: 8357933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the presence of a receptor for the cytolethal distending toxin (CLDT) of Campylobacter jejuni on CHO and HeLa cell membranes and development of a receptor-based enzyme-linked immunosorbent assay for detection of CLDT.
    Bag PK; Ramamurthy T; Nair UB
    FEMS Microbiol Lett; 1993 Dec; 114(3):285-91. PubMed ID: 8288105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis.
    Johnson WM; Lior H
    J Clin Microbiol; 1986 Aug; 24(2):275-81. PubMed ID: 3018039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolethal distending toxin (CLDT) production by enteropathogenic Escherichia coli (EPEC).
    Bouzari S; Varghese A
    FEMS Microbiol Lett; 1990 Sep; 59(1-2):193-8. PubMed ID: 2276608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of two cytotoxins produced by Campylobacter jejuni strains.
    Hänel I; Schulze F; Hotzel H; Schubert E
    Zentralbl Bakteriol; 1998 Jul; 288(1):131-43. PubMed ID: 9728413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of cytotoxins by enteric Campylobacter in humans and animals.
    Schulze F; Hänel I; Borrmann E
    Zentralbl Bakteriol; 1998 Oct; 288(2):225-36. PubMed ID: 9809404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro adherence property of cytolethal distending toxin (CLDT) producing EPEC strains and effect of the toxin on rabbit intestine.
    Bouzari S; Vatsala BR; Varghese A
    Microb Pathog; 1992 Feb; 12(2):153-7. PubMed ID: 1584007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of virulence-associated genes and cytolethal distending toxin production in Campylobacter spp. isolated in Italy.
    Ripabelli G; Tamburro M; Minelli F; Leone A; Sammarco ML
    Comp Immunol Microbiol Infect Dis; 2010 Jul; 33(4):355-64. PubMed ID: 19195703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of protein purification methods for the enrichment of a cytotoxin from Campylobacter jejuni.
    Gatsos X; Steer DL; Junaid TA; Smith AI; Adler B; Albert MJ
    BMC Microbiol; 2012 Dec; 12():303. PubMed ID: 23259594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.
    Lin CD; Lai CK; Lin YH; Hsieh JT; Sing YT; Chang YC; Chen KC; Wang WC; Su HL; Lai CH
    Infect Immun; 2011 Sep; 79(9):3563-75. PubMed ID: 21730089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of cytolethal distending toxin (cdt) genes among Campylobacter jejuni, C. coli and C. fetus strains.
    Asakura M; Samosornsuk W; Taguchi M; Kobayashi K; Misawa N; Kusumoto M; Nishimura K; Matsuhisa A; Yamasaki S
    Microb Pathog; 2007; 42(5-6):174-83. PubMed ID: 17353111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of crude Campylobacter jejuni heat-labile enterotoxin.
    Klipstein FA; Engert RF
    Infect Immun; 1984 Aug; 45(2):314-9. PubMed ID: 6746090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of outer membrane proteins of Campylobacter species with cholera toxin.
    Albert MJ
    Indian J Med Res; 2011 Feb; 133(2):207-11. PubMed ID: 21415496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations.
    Klipstein FA; Engert RF; Short H; Schenk EA
    Infect Immun; 1985 Oct; 50(1):43-9. PubMed ID: 3899937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of toxin production by thermophilic Campylobacter of animal origin.
    McFarland BA; Neill SD
    Vet Microbiol; 1992 Feb; 30(2-3):257-66. PubMed ID: 1313623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera-like enterotoxin produced by Campylobacter jejuni. Characterisation and clinical significance.
    Ruiz-Palacios GM; Torres J; Torres NI; Escamilla E; Ruiz-Palacios BR; Tamayo J
    Lancet; 1983 Jul; 2(8344):250-3. PubMed ID: 6135079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytolethal distending toxin gene-based multiplex PCR assay for detection of Campylobacter spp. in stool specimens and comparison with culture method.
    Shiramaru S; Asakura M; Inoue H; Nagita A; Matsuhisa A; Yamasaki S
    J Vet Med Sci; 2012 Jul; 74(7):857-62. PubMed ID: 22322187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a unique cytotoxin by Campylobacter jejuni.
    Guerrant RL; Wanke CA; Pennie RA; Barrett LJ; Lima AA; O'Brien AD
    Infect Immun; 1987 Oct; 55(10):2526-30. PubMed ID: 3653987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.